Bernhardt G. Zeiher's most recent trade in Entrada Therapeutics Inc was a trade of 19,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Entrada Therapeutics Inc | Bernhardt G. Zeiher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Amylyx Pharmaceuticals Inc | Bernhardt G. Zeiher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Amylyx Pharmaceuticals Inc | Bernhardt G. Zeiher | Director | Purchase of securities on an exchange or from another person at price $ 3.70 per share. | 20 Mar 2025 | 10,000 | 10,000 | - | 3.7 | 37,005 | Common Stock |
| Abeona Therapeutics Inc | Bernhardt G. Zeiher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 36,101 | 47,145 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Bernhardt G. Zeiher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 11,044 | 11,044 (0%) | 0% | 0 | Common Stock | |
| Entrada Therapeutics Inc | Bernhardt G. Zeiher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Amylyx Pharmaceuticals Inc | Bernhardt G. Zeiher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 5,753 | 5,753 | - | - | Stock Option (right to buy) | |
| Amylyx Pharmaceuticals Inc | Bernhardt G. Zeiher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Bernhardt G. Zeiher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) |